Risk Stratification and Pain Outcomes Following Revision Total Hip Arthroplasty for Adverse Local Tissue Reactions
Akshay V Daji1, Kalain K Workman2, Charlie J Yoo2
1Department of Orthopaedic Surgery, HCA Florida JFK/University of Miami Miller School of Medicine, Palm Beach, Florida.
The Journal of Arthroplasty
|June 23, 2022
Summary
Revision hip arthroplasty for adverse local tissue reactions (ALTR) significantly reduces pain. Risk stratification factors did not predict complications, but a lower cobalt-chromium ratio indicated higher complication risk.
Area of Science:
- Orthopedic surgery
- Biomaterials science
- Patient outcomes research
Background:
- Revision total hip arthroplasty (THA) for adverse local tissue reactions (ALTRs) due to head-neck taper corrosion has a high complication rate.
- ALTR diagnosis relies on patient history, implant factors, metal ion levels, and imaging.
- This study investigates risk factor predictability for revision THA outcomes in metal-on-polyethylene (MoP) ALTR cases.
Purpose of the Study:
- To evaluate if established risk stratification factors predict outcomes in patients undergoing revision THA for MoP ALTR.
- To analyze pain relief and complication rates following revision THA for ALTR.
Main Methods:
- Retrospective review of 141 patients undergoing revision THA for ALTR caused by head-neck taper corrosion.
- Analysis of pain outcomes using a generalized linear mixed model.
- Complications defined as instability, dislocation, infection, fracture, nerve palsy, leg-length discrepancy, or reoperation.
Main Results:
- Overall complication rate was 17.7%.
- Significant pain reduction observed post-revision (OR=0.56).
- Decreased cobalt-chromium ratio correlated with increased postoperative complications (P=0.002).
Conclusions:
- Revision THA for ALTR in MoP implants provides substantial pain relief.
- Femoral head offset adjustments did not impact instability/dislocation rates.
- Risk stratification factors require further investigation for predicting complications in ALTR revision THA.


